Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Dermatitis; Dermatitis, Atopic; Eczema Phase 2 ClinicalTrials
CONTENTS